Boothbay Fund Management, LLC Biomarin Pharmaceutical Inc Call Options Transaction History

Boothbay Fund Management, LLC

  • $3.37 Billion
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$71.48 - $86.85 $4.08 Million - $4.96 Million
-57,100 Reduced 83.72%
11,100 $920,000
Q1 2022

May 16, 2022
BUY
$74.28 - $92.69 $4.24 Million - $5.29 Million
57,100 Added 514.41%
68,200 $5.26 Million
Q4 2021

Feb 14, 2022
BUY
$71.72 - $91.47 $796,092 - $1.02 Million
11,100 New
11,100 $981,000

Others Institutions Holding BMRN

# of Institutions
632
Shares Held
185M
Call Options Held
1.63M
Put Options Held
1.2M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email